[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BPharmCatalyst "BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next X Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-14 13:17:37 UTC 29.8K followers, 7239 engagements

"BioPharmCatalyst Weekly #Watchlist Key Phase X Catalysts for the Next X Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-06-30 13:53:24 UTC 29.8K followers, 6325 engagements

"$MGRM will be acquired by $ZBH for $XXXX per share in cash totaling an equity value of $XXX million and an enterprise value of $XXX million. MGRM stockholders will also receive a non-tradeable contingent value right (CVR) of up to $XXXXX per share if product development regulatory and revenue milestones are met by 2030. See More Biotech Updates👇 $SONN $IPA $MGRM $DARE $BDRX $EPIX $DARE $SXTP"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-14 20:43:02 UTC 29.8K followers, 2062 engagements

"🎧 New Episode Alert On Biotech Bulls and Breakthroughs John Gagliano and Sheff break down: 🔹 Key biotech market trends 🔹 Catalyst-driven trading strategies 🔹 Small-cap opportunities"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-14 11:38:00 UTC 29.8K followers, 178K engagements

"Biotech updates 04/12: $BHVN buyout chatter +20% $TCON mid-stage fail -XX% $CLVS halts bladder trial -XX% $JNJ erdafitinib FDA approval $RNN reverse split $VTL - $IMUX Monday $BMY $CELG holders vote yes Pipeline updates $GLYC $HZNP $MNK $WVE"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2019-04-13 00:09:18 UTC 29.8K followers, XX engagements

"$ABVX shares are halted following results that its 50mg obefazimod achieved XXXX% pooled placebo-adjusted clinical remission at X weeks in Phase X ABTECT induction trials for moderate-to-severe UC meeting all key secondary endpoints with favorable safety. Maintenance data is due 2Q 2026 ahead of planned NDA/MAA submissions in 2H 2026. The company also delayed 1H 2025 financial results from August XX to September X 2025. Preliminary cash and cash equivalents as of June XX 2025 were approximately $XXXX million (unaudited). See More Biotech Updates👇 $IOVA $REPL $PMN $QNTM $STRO $AMIX $ABVX"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-22 20:51:45 UTC 29.8K followers, 3821 engagements

"Biotech updates 06/06 $LJPC data +92% $XERS PDUFA 3mth extension -XX% (-5% AH) $PLX Fabry BLA filing 1Q 2020 +35% $CRSP +10% (AH) DMD license with $VRTX $MTFB further trials reqd -XX% $JAGX r/split -XX% $INSY to pay $225m +33% $CELG ozanimod PDFUA 3/25"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2019-06-07 00:06:29 UTC 29.8K followers, XX engagements

"$MRK will acquire $VRNA for $XXX per ADS in a deal valued at approximately $XX billion securing full ownership of Veronas respiratory drug assets. See More Pre-market Movers 👇 $KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-09 12:33:08 UTC 29.8K followers, 5769 engagements

"$WINT signed a $60M securities purchase agreement led by Build and Build Corp with the potential to raise a total of $200M to launch a BNB crypto treasury strategy. Subject to shareholder approval Windtree aims to become the first NASDAQ-listed company offering direct BNB token exposure. See More Pre-market Movers 👇 $WINT $SRPT $PRTC $RCKT $NUWE"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-17 12:23:48 UTC 29.8K followers, 4343 engagements

"$SONN announced a business combination with Rorschach I LLC to form Hyperliquid Strategies Inc (HSI) a crypto treasury company expected to hold $888M in assets including 12.6M HYPE tokens and $305M in cash. HSI will remain listed on Nasdaq with backing from top crypto investors. See More Pre-market Movers 👇 $RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-14 12:23:23 UTC 29.8K followers, 5089 engagements

"$ITOS to be acquired by Concentra Biosciences for $10.047/share in cash plus a CVR tied to net cash above $475M and potential asset sales; tender offer to begin by Aug X 2025. See More Pre-market Movers 👇 $PMN $HSDT $ZIMV $SABS $NCNA $AUTL $EVO"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-21 12:20:13 UTC 29.8K followers, 6046 engagements

"Biotech 6/10 $INSY BK -XX% $PRVB diabetes data +217% $RHHBY $SGEN DLBCL FDA approval $NBY +875% $GTXI-$ONCT $APTX +15% $SESN BLA 4Q -XX% $RHHBY $ONCE -X% delays $NVAX further trial reqd-12% Pipeline updates $ACHN $ADXS $ARPO $ARQL $BTAI $INNT $KZR $NVAX"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2019-06-11 00:11:00 UTC 29.8K followers, XX engagements

"$CLSD initiated a strategic review to explore options including asset sales partnerships or M&A to advance its SCS platform; Piper Sandler retained to lead the process. See More Biotech Updates👇 $WINT $SRPT $RCKT $FOLD $MBRX $CLSD $ICU"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-17 20:25:54 UTC 29.8K followers, 5545 engagements

"Biotech updates 06/17: $ARRY buyout $PFE +57% $VBIV late-stage data -XX% $QURE buyout chatter +12% $BHVN offering -XX% AH $FLKS more votes req'd -XX% $RMTI offering -XX% AH $CALA data + offering Pipe updates $ACRS $ALNY $ARNA $ARQL $HEB $ISEE $PHAS $PLX"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2019-06-17 23:58:18 UTC 29.8K followers, XX engagements

"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next X Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-12 13:18:12 UTC 29.8K followers, 6920 engagements

"$NUWE announced the issuance by the U.S Patent and Trademark Office of U.S. Patent No. 12357734 titled "Extracorporeal Blood Filtering Machine and Methods." See More Biotech Updates👇 $SXTP $PMN $ANGO $BCTX $RANI $IKNA $KZR"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-15 20:49:05 UTC 29.8K followers, 2991 engagements

"$PMN shares closed up after the company announced that PMN310 its lead therapeutic candidate for Alzheimer's received FDA Fast Track designation. See More Biotech Updates👇 $PMN $ZIMV $EVO $SABS $HOOK $SLRX $CLSD $GDTC"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-21 20:58:48 UTC 29.8K followers, 2293 engagements

"BioPharmCatalyst Weekly #Watchlist Key Catalysts Due in Mid-2025 $REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-19 15:00:00 UTC 29.8K followers, 6463 engagements

"$TELO reported promising data for Telomir-1 which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-18 12:20:59 UTC 29.8K followers, 2438 engagements

"$MIST received a new PDUFA date of Dec XX 2025 for CARDAMYST nasal spray for PSVT after FDA accepted its CRL resubmission. The company also extended its $75M royalty deal with RTW through year-end. Separately Milestone priced a $52.5M public offering of common and pre-funded warrants at $1.50/share expected to close July XX 2025. See More Biotech Updates👇 $NCNA $INKT $MIST $CAPR $JUNS $PHVS $DARE"
@BPharmCatalyst Avatar @BPharmCatalyst on X 2025-07-11 20:16:19 UTC 29.8K followers, 6145 engagements